Pesquisas alternativas:
drug codes » drug code (Expandir a Pesquisa), drug costs (Expandir a Pesquisa)
drug doses » drug dose (Expandir a Pesquisa)
devel ther » novel ther (Expandir a Pesquisa), level theory (Expandir a Pesquisa), develop them (Expandir a Pesquisa)
drug does » drugs does (Expandir a Pesquisa), drug dose (Expandir a Pesquisa), drug de (Expandir a Pesquisa)
drug dnav » drug deal (Expandir a Pesquisa), drug da (Expandir a Pesquisa), drug day (Expandir a Pesquisa)
drug codes » drug code (Expandir a Pesquisa), drug costs (Expandir a Pesquisa)
drug doses » drug dose (Expandir a Pesquisa)
devel ther » novel ther (Expandir a Pesquisa), level theory (Expandir a Pesquisa), develop them (Expandir a Pesquisa)
drug does » drugs does (Expandir a Pesquisa), drug dose (Expandir a Pesquisa), drug de (Expandir a Pesquisa)
drug dnav » drug deal (Expandir a Pesquisa), drug da (Expandir a Pesquisa), drug day (Expandir a Pesquisa)
1
“... are constantly under pressure, higher percentages of drugs are demanded, and the drug-discovery process is a...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
2
Por Park, Gab-jin, Bae, Soo Hyeon, Park, Wan-Su, Han, Seunghoon, Park, Min-Ho, Shin, Seok-Ho, Shin, Young G, Yim, Dong-Seok
Publicado no Drug Des Devel Ther (2017)
“...PURPOSE: A microdose drug–drug interaction (DDI) study may be a valuable tool for anticipating drug...”Publicado no Drug Des Devel Ther (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
3
4
“..., there is an urgent need for new antimalarial drugs, with single-dose cures, broad therapeutic potential, and novel...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
5
“..., this study aimed to evaluate the pharmacokinetic (PK) interactions between these two drugs in healthy males...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
6
Por Lee, Jieon, Rhee, Su-jin, Lee, SeungHwan, Yu, Kyung-Sang
Publicado no Drug Des Devel Ther (2018)
“... dose or as multiple doses to healthy Caucasians. METHODS: Thirty-six subjects were enrolled...”Publicado no Drug Des Devel Ther (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
7
Por Wu, Jianhui, Zhao, Ming, Wang, Yuji, Wang, Yaonan, Zhu, Haimei, Zhao, Shurui, Gui, Lin, Zhang, Xiaoyi, Peng, Shiqi
Publicado no Drug Des Devel Ther (2017)
“... S180 mice, and has a minimal effective dose of 2 nmol/kg per day. At 200 nmol/kg per day, HMCEF does...”Publicado no Drug Des Devel Ther (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
8
“..., accumulates DNA damage, and induces p53-independent cell death, but the same treatment in normal cells does...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
9
“..., we aimed to determine the effect of different timing of ondansetron administration on the dose...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
10
Por Choi, Suein, Jeon, Sangil, Yim, Dong-Seok, Han, Seunghoon
Publicado no Drug Des Devel Ther (2020)
“... was the major difference between scenarios. CONCLUSION: In multiple-dose studies on drugs with delayed...”Publicado no Drug Des Devel Ther (2020)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
11
Por Kim, Sang-Mi, Lee, Hyun-Seung, Hwang, Na-Young, Kim, Kyunga, Park, Hyung-Doo, Lee, Soo-Youn
Publicado no Drug Des Devel Ther (2021)
“... of pharmacokinetic-guided (PK) dosing of vancomycin are limited. AIM: We evaluated the pharmacokinetic and clinical...”Publicado no Drug Des Devel Ther (2021)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
12
Por Lian, Le-jing, Lin, Bin, Cui, Xiao, He, Jie, Wang, Zhe, Lin, Xiao-dong, Ye, Wei-jian, Chen, Rui-jie, Sun, Wei
Publicado no Drug Des Devel Ther (2020)
“...-dose MTX individualization therapy in acute lymphoblastic leukemia (ALL) children to avoid serious...”Publicado no Drug Des Devel Ther (2020)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
13
Por Kalam, Muhammad Nasir, Rasool, Muhammad Fawad, Alqahtani, Faleh, Imran, Imran, Rehman, Asim Ur, Ahmed, Naveed
Publicado no Drug Des Devel Ther (2021)
“... based pharmacokinetic (PBPK) model-building approach for suggesting model informed propranolol dosing...”Publicado no Drug Des Devel Ther (2021)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
14
Por Tsagogiorgas, Charalambos, Anger, Friedrich, Beck, Grietje, Breedijk, Annette, Yard, Benito, Hoeger, Simone
Publicado no Drug Des Devel Ther (2019)
“...H8-cEM and their drug delivery properties. Afterward, an in vivo study was performed as a proof...”Publicado no Drug Des Devel Ther (2019)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
15
Por Lee, Jieon, Yoon, Seonghae, Shin, Donghoon, Han, HyeKyung, An, Hyungmi, Lee, Jongtae, Lim, Kyoung Soo, Yu, Kyung-Sang, Lee, Howard
Publicado em 2014
“... nomograms may be required in patients with IE, particularly for once-daily dosing. Therapeutic drug...”Publicado em 2014
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
16
Por Gavazzoni, Mara, Gorga, Elio, Derosa, Giuseppe, Maffioli, Pamela, Metra, Marco, Raddino, Riccardo
Publicado no Drug Des Devel Ther (2017)
“...BACKGROUND AND AIM: Clinical benefits of early high-dose statin therapy after acute coronary...”Publicado no Drug Des Devel Ther (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
17
Por Wong, Yi-Sin, Sung, Sheng-Feng, Wu, Chi-Shun, Hsu, Yung-Chu, Su, Yu-Hsiang, Hung, Ling-Chien, Ong, Cheung-Ter
Publicado no Drug Des Devel Ther (2020)
“... of 10% of the total dose given within 1–2 mins is the standard therapy for patients receiving...”Publicado no Drug Des Devel Ther (2020)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
18
Por Guerrero-Orriach, Jose Luis, Escalona Belmonte, Juan Jose, Ramirez Fernandez, Alicia, Ramirez Aliaga, Marta, Rubio Navarro, Manuel, Cruz Mañas, Jose
Publicado no Drug Des Devel Ther (2017)
“... is related to the dose-dependent signal, while the degree of protection is related to the concentration...”Publicado no Drug Des Devel Ther (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
19
Por Barbarash, Olga, Gruzdeva, Olga, Uchasova, Evgenya, Belik, Ekaterina, Dyleva, Yulia, Karetnikova, Victoria
Publicado no Drug Des Devel Ther (2015)
“..., resulted in a decrease in free fatty acid levels. The positive effect of low-dose atorvastatin (20 mg/day...”Publicado no Drug Des Devel Ther (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
20
Por Kasıkara, Hulya, Sungu, Nuran, Arslan, Mustafa, Kucuk, Aysegul, Ozturk, Levent, Afandiyeva, Nigar, Kavutcu, Mustafa
Publicado no Drug Des Devel Ther (2021)
Obter o texto integralPublicado no Drug Des Devel Ther (2021)
Obter o texto integral
Obter o texto integral
Artigo